MacCallum P, Tolhurst JC, Buckle G, Sissons HA, 1948. A new mycobacterial infection in man. J Pathol Bacteriol 60: 93–102.
Aubry P, Gaüzère BA, 2020. Ulcère de Buruli. Available at: http://medecinetropicale.free.fr/cours/ulcere_buruli.pdf. Accessed Januray 22, 2020.
Zingue D, Bouam A, Tian RBD, Drancourt M, 2017. Buruli ulcer, a prototype for ecosystem-related infection, caused by Mycobacterium ulcerans. Clin Microbiol Rev 31: e00045-17.
George KM et al. 1999 Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854–857.
Alcock BP et al. 2020. Card 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res 48: D517–D525.
Buultjens AH et al. 2018. Comparative genomics shows that Mycobacterium ulcerans migration and expansion preceded the rise of Buruli ulcer in southeastern Australia. Appl Environ Microbiol 84: e02612-17.
Portaels F et al. 2008. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2: e178.
Tai AYC, Athan E, Friedman ND, Hughes A, Walton A, O’Brien DP, 2018. Increased severity and spread of Mycobacterium ulcerans, southeastern Australia. Emerg Infect Dis 24: 58–64.
Vandelannoote K et al. 2017. Multiple introductions and recent spread of the emerging human pathogen Mycobacterium ulcerans across Africa. Genome Biol Evol 9: 414–426.
Hammoudi N, Saad J, Drancourt M, 2020. The diversity of mycolactone-producing mycobacteria. Microb Pathog 149: 104362.
Page AJ et al. 2015. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 31: 3691–3693.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 647 | 187 | 0 |
Full Text Views | 251 | 149 | 27 |
PDF Downloads | 152 | 77 | 14 |
Mycobacterium ulcerans, the opportunistic pathogen causing Buruli ulcer, is reported to affect rural populations in 36 tropical countries. We report one case of Buruli ulcer in a peri-urban area in Côte d’Ivoire, confirmed by whole genome sequencing which indicated a M. ulcerans genotype previously unreported in Côte d’Ivoire.
Financial support: N. H. obtained a PhD grant from the Fondation Méditerranée Infection, Marseille, France. This work was supported by the Agence Nationale de la Recherche (ANR-17-CE35-0006-01 PRIME, http://www.agencenationale-recherche.fr/) and by the French government under the “Investissements d’Avenir” (Investments in the Future) program managed by the A. N. R. (reference: Méditerranée Infection 10-IAHU-03). This work was supported by Région Le Sud (Provence Alpes Côte d’Azur) and European FEDER IHUBIOTK funding.
Authors’ addresses: Philippe Bahadoran and Yoan Di Filippo, Centre Hospitalier Universitaire de Nice, Dermatology, Nice, Provence-Alpes-Côte d'Azur, France, E-mails: bahadoran.P@chu-nice.fr and difilippo.y@chu-nice.fr. Nassim Hammoudi, Jamal Saad, and Michel Drancourt, Aix-Marseille Universite, MEPHI, Marseille, Provence-Alpes-Côte d'Azu, France, E-mails: nassimveto15@live.fr, jsaad270@gmail.com, and michel.drancourt@univ-amu.fr. Alice Gaudart, Laboratoire de Bactériologie, Centre Hospitalier, Universitaire de Nice, Hôpital de l'Archet II, Nice, France, E-mail: gaudart.a@chu-nice.fr. Raymond Ruimy, Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, Hôpital de l'Archet II, Laboratoire de Bacteriologie, 151, Route de St Antoine de Ginestière, Nice, France, and Inserm, C3M, Team 6, Nice, France, E-mail: ruimy.r@chu-nice.fr.